The DOI matches its Crossref record.
AVE 0991, a Nonpeptide Mimic of the Effects of Angiotensin-(1–7) on the Endothelium
Abstract
Recently, we demonstrated that the heptapeptide angiotensin-(1–7) (Ang-[1–7]) exhibits a favorable kinetic of nitric oxide (NO) release accompanied by extremely low superoxide (O 2 − ) production. In this report we describe AVE 0991, a novel nonpeptide compound that evoked effects similar to Ang-(1–7) on the endothelium. AVE 0991 and unlabeled Ang-(1–7) competed for high-affinity binding of [ 125 I]-Ang-(1–7) to bovine aortic endothelial cell membranes with IC 50 values of 21±35 and 220±280 nmol/L, respectively. Stimulated NO and O 2 − release from bovine aortic endothelial cells was directly and simultaneously measured on the cell surface by selective electrochemical nanosensors. Peak concentrations of NO and O 2 − release by AVE 0991 and Ang-(1–7) (both 10 μmol/L) were not significantly different (NO: 295±20 and 270±25 nmol/L; O 2 − : 18±2 and 20±4 nmol/L). However, the released amount of bioactive NO was ≈5 times higher for AVE 0991 in comparison to Ang-(1–7). The selective Ang-(1–7) antagonist [D-Ala 7 ]-Ang-(1–7) inhibited the AVE 0991–induced NO and O 2 − production by ≈50%. A similar inhibition level was observed for the Ang II AT 1 receptor antagonist EXP 3174. In contrast, the Ang II AT 2 receptor antagonist PD 123,177 inhibited the AVE 0991–stimulated NO production by ≈90% but without any inhibitory effect on O 2 − production. Both NO and O 2 − production were inhibited by NO synthase inhibition (≈70%) and by bradykinin B 2 receptor blockade (≈80%). AVE 0991 efficiently mimics the effects of Ang-(1–7) on the endothelium, most probably through stimulation of a specific, endothelial Ang-(1–7)-sensitive binding site causing kinin-mediated activation of endothelial NO synthase.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The ACE2/angiotensin-(1-7)/MAS Axis of the renin-angiotensin system: focus on angiotensin-(1-7)
Santos, R. A. S., Sampaio, W. O., Alzamora, A. C., Motta-Santos, D., Alenina, N., Bader, M., & Campagnole-Santos, M. J. (2018) · Physiological Reviews · doi:10.1152/physrev.00023.2016 · Cited by 1,144
Counter-regulatory renin–angiotensin system in cardiovascular disease
Paz Ocaranza, M., Riquelme, J. A., García, L., Jalil, J. E., Chiong, M., Santos, R. A. S., & Lavandero, S. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0244-8 · Cited by 561
ACE2, angiotensin‐(1‐7) and Mas receptor axis in inflammation and fibrosis
Simões e Silva, A., Silveira, K., Ferreira, A., & Teixeira, M. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12159 · Cited by 542
Li, X. C., Zhang, J., & Zhuo, J. L. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.06.005 · Cited by 435
Arendse, L. B., Danser, A. H. J., Poglitsch, M., Touyz, R. M., Burnett, J. C., Llorens-Cortes, C., Ehlers, M. R., & Sturrock, E. D. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.017129 · Cited by 339
Metadata
- Authors
- Wiemer, G., Dobrucki, L. W., Louka, F. R., Malinski, T., & Heitsch, H.
- Venue
- Hypertension
- Published
- 2002-12
- Volume
- 40
- Issue
- 6
- Pages
- 847-852
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2159872857
- Cited by
- 199
- References
- 0
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: AVE 0991, a Nonpeptide Mimic of the Effects of Angiotensin-(1–7) on the Endothelium. https://app.cochat.ai/papers/10.1161/01.hyp.0000037979.53963.8f
- The paper
- Wiemer, G., Dobrucki, L. W., Louka, F. R., Malinski, T., & Heitsch, H. (2002). AVE 0991, a Nonpeptide Mimic of the Effects of Angiotensin-(1–7) on the Endothelium. Hypertension. https://doi.org/10.1161/01.hyp.0000037979.53963.8f
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.